Viewing Study NCT02138812


Ignite Creation Date: 2025-12-26 @ 11:13 PM
Ignite Modification Date: 2025-12-26 @ 11:13 PM
Study NCT ID: NCT02138812
Status: TERMINATED
Last Update Posted: 2018-10-12
First Post: 2014-05-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module